NASDAQ · CELZ
Creative Medical Technology Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CELZ: Nov 6, 2026
Creative Medical Technology Holdings, Inc. Common Stock is estimated to report earnings on 11/06/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.24. The reported EPS for the same quarter last year was $-0.48.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.24 | $-0.24 | $-0.24 | 1 |
| Dec 2026 | $-0.24 | $-0.24 | $-0.24 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks- RTTNews · Oct 20, 11:29 AM EDTCreative Medical Reports 93% Response Rate In Ultrasome Knee Osteoarthritis Pilot Study(RTTNews) – Tuesday, Creative Medical Technology Holdings (CELZ) said its investigational Ultrasome platform showed a 93% patient response rate and an approximately 65% reduction in average pain scores in a knee osteoarthritis pilot study.
- RTTNews · Sep 18, 12:17 PM EDTCreative Medical Expands Ultrasome Intellectual Property Portfolio(RTTNews) – Creative Medical Technology Holdings (CELZ), a biotechnology company developing regenerative medicine technologies, has filed a new U.S. provisional patent application to expand intellectual property protection for its Ultrasome platform. Ultrasome is a proprietary
- RTTNews · Aug 20, 9:47 AM EDTCreative Medical Completes ADAPT Trial Enrollment; Advances Olastrocel; Stock Up(RTTNews) – Creative Medical Technology Holdings, Inc. (CELZ), a clinical-stage biotechnology company developing regenerative medicine therapies, announced that it has completed enrollment and treatment across all cohorts of its FDA-cleared ADAPT trial evaluating CELZ-201, also k
- RTTNews · Aug 6, 10:30 PM EDTTop Biotech Gainers: CELZ Soars On Patent News, BRVE Debuts Strong, IOVA Revenue Climbs 66%(RTTNews) – Today's top gainers in the biotech space include Creative Medical, boosted by a new U.S. patent covering exosome-based immunotherapy for Type 1 diabetes; Braveheart, following its IPO; Iovance, after reporting a 66% increase in second-quarter revenue; and Sight Scienc
- RTTNews · Jul 1, 10:33 AM EDTCreative Medical Technology Issues 2026 Mid-Year Update; Stock Down(RTTNews) – Creative Medical Technology Holdings, Inc. (CELZ), a clinical-stage biotechnology company, issued a mid-year update from its President and CEO, Timothy Warbington.
- RTTNews · Jul 1, 4:07 AM EDTCreative Medical Technology Holdings Secures $4.5 Million Through Warrant Exercises(RTTNews) – Shares of Creative Medical Technology Holdings, Inc. (CELZ) rose as much as 78% during yesterday's trading session after the company announced agreements for the exercise of the existing warrants, generating approximately $4.5 million in gross proceeds.
- RTTNews · Jun 23, 5:20 AM EDTCreative Medical Technology Expands ADAPT Trial After New FDA Clearance(RTTNews) – Creative Medical Technology Holdings, Inc. (CELZ) has received new FDA clearance to expand its ADAPT clinical trial evaluating Olastrocel (CELZ-201) for chronic lower back pain, marking another step forward as the company moves toward Phase 3 planning for the regenera
- RTTNews · Jun 16, 10:03 AM EDTCreative Medical Technology Advances Project PHOENIX Into National Wide AI-Driven Data Collection(RTTNews) – Creative Medical Technology Holdings, Inc. (CELZ) has advanced Project PHOENIX into a nationwide virtual data-collection phase, marking the next operational milestone for its regulatory-approved, AI-driven registry designed to support U.S. veterans exposed to burn pit
- RTTNews · Jan 13, 10:50 AM ESTCreative Medical's ADAPT Trial In Chronic Lower Back Pain Shows Functional And Pain Improvements(RTTNews) – Creative Medical Technologies Holdings Inc. (CELZ) reported what it called a major clinical infection point after releasing positive interim 180-day data from its FDA-cleared ADAPT trial.
- RTTNews · Dec 18, 3:53 AM ESTCreative Medical Wraps Up ADAPT Trial Enrollment For Chronic Lower Back Pain(RTTNews) – Creative Medical Technology Holdings, Inc. (CELZ), a clinical-stage biotechnology company, has completed patient enrolment in its FDA-cleared ADAPT clinical trial.
- Zacks · Nov 5, 9:55 AM ESTBears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' NowCreative Medical Technology Holdings, Inc. (CELZ) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- Zacks · Jul 31, 5:43 AM EDTNew Strong Sell Stocks for July 31stCELZ, GRFS and WHR have been added to the Zacks Rank #5 (Strong Sell) List on July 31, 2025.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Creative Medical Technology Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.